Details of the Drug Reposition

General Information of This Drug (ID: DMXN2ZQ)

• Drug Name: IMO-2134 (DMXN2ZQ)

Information on Drug Reposition of This Drug

2 Preclinical Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Allergy	DIS48ZAP	4A80-4A85	Preclinical	[1]
Asthma	DISW9QNS	CA23	Preclinical	[1]

References

• [1] Clinical pipeline report, company report or official report of Idera Pharmaceuticals (2011).